- Published at
- by manilatimes.net
positive
positive
News for Generation Bio Co. (GBIO)
- Published at
- by gurufocus.com
positivepositiveGeneration Bio to Present at the TD Cowen 45th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (GBIO), a biotechnology company working to change what's possible for people living wit- Published at
- by gurufocus.com
positivepositiveFMR LLC Reduces Stake in Generation Bio Co: Analyzing the Implications
Overview of FMR LLC (Trades, Portfolio)'s Recent Transaction On December 31, 2024, FMR LLC (Trades, Portfolio) executed a significant transaction involving Gene- Published at
- by finance.yahoo.com
neutralneutral- Published at
- by gurufocus.com
positivepositiveGeneration Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
Novel programs will combine validated cell-targeted LNP (ctLNP) delivery with siRNA to selectively modulate T cells in vivoPrograms to focus on silencing hard-t- Published at
- by manilatimes.net
positivepositive- Published at
- by zacks.com
positivepositiveGeneration Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates
Generation Bio (GBIO) delivered earnings and revenue surprises of 17.86% and 249.24%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by markets.businessinsider.com
positivepositiveEQS-News: BB Biotech: Strategic reallocation of portfolio assets progressing
EQS-News: BB Biotech AG / Key word(s): Interim Report BB Biotech: Strategic reallocation of portfolio assets progressing ...- Published at
- by manilatimes.net
neutralneutral- Published at
- by globenewswire.com
neutralneutralGeneration Bio to Present at the 2024 Cantor Global Healthcare Conference
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people...- Published at
- by globenewswire.com
mixedmixedDyne Therapeutics Announces Key Leadership Appointments
- Building Team to Prepare for Commercialization as Company Pursues Expedited Approval Pathways for DM1 and DMD Clinical Programs - WALTHAM, Mass., Sept. ...- Published at
- by benzinga.com
mixedmixedGeneration Bio Co. Reports Q2 Loss, Tops Revenue Estimates - Generation Bio (NASDAQ:GBIO), HOOKIPA Pharma (NASDAQ:HOOK)
Generation Bio Co. (NASDAQ: GBIO) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items.- Published at
- by financialpost.com
mixedmixedenGene Announces Appointment of Ron Cooper as Chief Executive Officer
Ron Cooper succeeds Jason Hanson as Chief Executive Officer and Director Ron Cooper succeeds Jason Hanson as Chief Executive Officer and Director Company also…- Published at
- by globenewswire.com
mixedmixedC4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
Cooper Brings Decades of Global Pharmaceutical and Biotechnology Leadership Experience Bruce Downey Remains a Member of the Board of Directors and Chair...- Published at
- by marketscreener.com
positivepositiveBB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...- Published at
- by globenewswire.com
mixedmixedTenaya Therapeutics Reports First Quarter 2023 Financial
TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned...- Published at
- by marketscreener.com
neutralneutralGeneration Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
CAMBRIDGE, Mass., Sept. 20, 2022 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of Phillip... | September 20, 2022- Published at
- by etfdailynews.com
mixedmixedContrasting Generation Bio (NASDAQ:GBIO) and Ainos (OTCMKTS:AIMD)
Read Contrasting Generation Bio (NASDAQ:GBIO) and Ainos (OTCMKTS:AIMD) at ETF Daily News- Published at
- by 247wallst.com
mixedmixedAbercrombie, Mattel, Western Digital and More Wednesday Afternoon Analyst Calls – 24
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Abercrombie & Fitch, Mattel, Radius Health and Western Digital.- Published at
- by marketscreener.com
mixedmixedDGAP-News : BB BIOTECH AG: I vaccini tracciano la -2-
Presidente eletto Biden potrebbe risultare sotto pressione per portare avanti la riforma dei prezzi dei farmaci. Ma in un anno in cui l'attenzione principale sar rivolta alle strategie per... | January 22, 2021